[Graves' disease in HIV patient receiving antiretroviral therapy].

Autor: Morgunova TB; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Zorina AA; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Maloletkina ES; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Sytch YP; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Vasileva AV; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Fadeyev VV; I.M. Sechenov First Moscow State Medical University (Sechenov University).
Jazyk: ruština
Zdroj: Problemy endokrinologii [Probl Endokrinol (Mosk)] 2020 Sep 16; Vol. 66 (3), pp. 22-26. Date of Electronic Publication: 2020 Sep 16.
DOI: 10.14341/probl12375
Abstrakt: The article focuses on the clinical case of Graves’ disease in a patient with HIV infection who is receiving antiretroviral therapy. The number of HIV-infected patients has increased significantly in recent decades all over the world. The currently used highly active antiretroviral therapy can significantly improve the prognosis for these patients. However, its use is associated with a number of complications, in particular the development of immune reconstitution syndrome, under which the development of such autoimmune diseases as Graves’ disease, polymyositis and Guillain-Barre syndrome may occur. Therefore, we would like to draw the attention of doctors to the possibility of such a complication in patients receiving antiretroviral therapy. Timely diagnosis and treatment of thyroid disorders will help to avoid the complications associated with an excess or deficit of thyroid hormones.
Databáze: MEDLINE